Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Bachem AG

Bachem is an independent, technology-based company, specialized in the production of innovative biochemicals for research purposes and pharmaceutical compounds for the pharma and biotech industries, as well as in the development of optimal manufacturing processes. Complementary services are geared to support customers from dedicated syntheses of defined target structures up to the registration of new compounds.



Bachem AG:-



Business responsibilities for Europe (excluding F, D, UK) and Asia

Research and development and regulatory affairs support

Distribution center for catalog products

Production of amino acid derivatives

Solution and solid phase synthesis


Contact Details:
Haupt strasse 144
Bubendorf
CH-4416
Switzerland
Tel:+41 61 935 2323
Fax: +41 61 935 2325
Email:
WWW:

www.bachem.com/




Recent Publications by Bachem AG:

Optimized coupling protocols for the incorporation of cys derivatives during Fmoc-SPPS.
BACKGROUND AND PURPOSE: The purpose of this study was to describe the...
6th June, 2009
Bachem AG, Bubendorf, Switzerland. Adv Exp Med Biol. 2009;611:163-4.
Formation of Fmoc-beta-alanine during Fmoc-protections with Fmoc-OSu.
During the Fmoc-protection of H-alpha-Me-Val-OH, an unknown side product...
19th August, 2008
Bachem AG, Bubendorf, Switzerland. J Pept Sci. 2008 Jun;14(6):763-6.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part III.
A newly developed Fmoc-Asp derivative, Fmoc-Asp...
16th November, 2005
Bachem AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2005 Oct;11(10):650-7.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part II.
The sequence dependence of base-catalysed aspartmide formation during...
30th March, 2004
BACHEM AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2003 Aug;9(8):518-26.
DOI Direct Link
The aspartimide problem in Fmoc-based SPPS. Part I.
A variety of Asp beta-carboxy protecting groups, Hmb backbone protection...
6th August, 2003
BACHEM AG, Hauptstr. 144, CH-4416 Bubendorf, Switzerland. J Pept Sci. 2003 Jan;9(1):36-46.
DOI Direct Link

View more Bachem AG research publications.

BioNews Results for Bachem AG:

Swiss companies aiming for peptide pinnacle
Drug Discovery News:  Nov 5 2009 10:59PM Matching: bachem ag

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1099 times since April 2007, the link to the organisation's website has been followed 198 times

Recent Search Terms used to find this page: bachem AG bubendorf email | Fmoc-Osu coupling on SPPS | Bachem Bubendorf Switzerland | Bachem Bubendorf | Bachem AG | The aspartimide problem in Fmoc-based SPPS. | beta-amino acids and bachem | bachem ag e-mail | bachem ag e-mail | E-MAIL DE BACHEM | .

Search for more companies in Bubendorf

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Bachem AG

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.